Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts New facility will create 200 new jobs and accelerate commercialization of gene and cell therapies LEXINGTON, Mass., Dec. 4, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and... Read more
https://www.agilent.com/about/newsroom/presrel/2019/03dec-ca19029.html Read more
Using STED super-resolution microscopy, researchers at the University of British Columbia have shed new light on the compartmentalization in peripheral ER tubules. Using the lumenal ER reporter ER monomeric oxidizing environment-optimized green fluorescent protein (ERmoxGFP), the team led by Dr. Ivan Nabi performed high-speed (40 ms/frame) live-cell STED imaging and characterized the behavior of the... Read more
WASHINGTON, Nov. 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Evercore ISI HealthCONx Conference on Thursday, December 5, 2019 at 8:45 a.m. ET. The audio will be simultaneously webcast and then archived on www.danaher.com. About DanaherDanaher is a global... Read more
Agilent Receives Multiple Life Science Industry Awards for Innovation Recognizing innovation and excellence in the life science industry SANTA CLARA, Calif., November 26, 2019 Agilent Technologies, Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the LSIA... Read more
https://www.agilent.com/about/newsroom/presrel/2019/25nov-gp19026.html Read more
Investment doubles the site’s process development capabilities and establishes commercial testing Read more
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) in Europe SANTA CLARA, Calif., November 22, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that its PD-L1... Read more
Agilent Announces Applications Open for LabCentral Golden Ticket Sponsorship will enable a promising biotech startup to advance scientific discovery SANTA CLARA, Calif., November 21, 2019 Agilent Technologies, Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and biotech startup... Read more